Neisseria meningitidis group a capsular polysaccharide diphtheria toxoid conjugate antigen is an active intramuscular immunization for the prophylaxis of invasive meningococcal disease caused by Neisseria meningitidis serogroup a. The vaccine... The vaccine contains N. meningitis serogroup a capsular polysaccharide antigens that are purified and individually conjugated to diphtheria toxoid protein that are extracted from Corynebacterium diphtheriae grown in another culture.
- First approval
- Canada, 2006 · United States, 2005
- Also known as
- Neisseria meningitidis serogroup A capsular polysaccharide diphtheria toxoid protein conjugate vaccine
- Brand names
Resolves to
What you can answer from here — as of January 07, 2026
Which other approved drugs treat the same conditions as Neisseria meningitidis group a capsular polysaccharide diphtheria toxoid conjugate antigen, and which companies have late-stage candidates in those indications?
Create a free account or log in to explore the full data card.
Create Account